Delivery Order SPE2DE24DA017-SPE2D625F4P8N
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,596.98 to Arthrex Inc. for an Implant System, SutureLoc on July 23, 2025. This fixed-price contract with economic price adjustment has a completion date of July 28, 2025, and will be performed in Naples, Florida. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. This delivery order is issued under...
- The U.S. Department of Defense's Defense Logistics Agency Medical Supply Chain awarded Arthrex Inc. a delivery order valued at $19,688.56 for an Implant System, SutureLoc on June 2, 2025, with completion scheduled for June 5, 2025. This fixed-price delivery order with economic price adjustment was issued under the agency's broader federal contracting vehicle and will be performed in Naples, Florida, where Arthrex maintains its headquarters. The award carries no set-aside designation,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $42,600.23 to Arthrex Inc. for an implant system featuring SutureLoc technology. The contract, issued on October 30, 2025, with an ultimate completion date of November 4, 2025, operates under a fixed-price structure with economic price adjustment provisions. This delivery order is issued without a set-aside designation, reflecting Arthrex's established competitive position as a primary supplier of orthopedic...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $41,272.55 for an Implant System, Sutureloc on August 7, 2025, with completion expected by August 12, 2025. This fixed-price delivery order with economic price adjustment is funded through the Defense Logistics Agency's Medical Supply Chain and was awarded without set-aside restrictions, reflecting Arthrex's strong competitive position in the federal...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order award valued at $4,400.88 for an Implant System, SutureLoc product from the Defense Logistics Agency's Medical Supply Chain on September 2, 2025. The contract, utilizing fixed-price pricing with economic price adjustment terms, is scheduled for completion by September 5, 2025, and will be performed in Naples, Florida. This delivery order award was not issued under any...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $4,400.88 for an Implant System, Sutureloc, on August 6, 2025. This fixed-price contract with economic price adjustment is set to be completed by August 11, 2025, and will be performed in Naples, Florida. The award was issued without set-aside designation, reflecting Arthrex's competitive strength in the federal orthopedic medical device marketplace. The...
- Arthrex Inc., a leading developer and manufacturer of minimally invasive orthopedic medical technologies based in Naples, Florida, has been awarded a fixed-price delivery order valued at $89,118.95 for an Implant System, SutureLoc. The contract, issued on September 25, 2025, with a completion date of September 30, 2025, was awarded without set-aside designation by the Defense Logistics Agency's Medical Supply Chain division. The delivery order will be fulfilled at Arthrex's Naples, Florida...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $5,932.74 to Arthrex Inc. for a Proximal Tenodesis Implant System, effective September 29, 2025, with an ultimate completion date of October 2, 2025. This fixed-price contract with economic price adjustment clauses was awarded without a set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. The contractor, headquartered in Naples,...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $29,392.78 for an implant system called Sutureloc. The award, issued on November 24, 2025, with an ultimate completion date of November 28, 2025, is fixed-price with economic price adjustment provisions and carries no set-aside designation. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, which procures orthopedic...
- Arthrex Inc., a leading minimally invasive orthopedic medical technology company headquartered in Naples, Florida, was awarded a delivery order valued at $4,400.88 on August 6, 2025, for an Implant System, Sutureloc product. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 11, 2025, and will be performed in Naples, Florida. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F4P8NDelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $8,066.83 to Arthrex Inc. for an Implant System, Sutureloc on April 24, 2025, with completion scheduled for April 29, 2025. This fixed-price delivery order with economic price adjustment was issued under a non-competitive award with no set-aside designation. Arthrex, headquartered in Naples, Florida, is a global leader in minimally invasive orthopedic medical technologies and surgical implants, serving primarily Department of Veterans Affairs and Department of Defense healthcare systems. The company holds a significant single-award Indefinite Delivery Contract with the Defense Logistics Agency (SPE2DE24D0020) valued at $471 million through September 2029, which enables VA medical centers nationwide to procure from Arthrex's comprehensive portfolio of orthopedic solutions. This delivery order represents a task order under Arthrex's existing Defense Logistics Agency IDC and continues the company's consistent provision of advanced orthopedic surgical products to government healthcare systems. The Sutureloc implant system is part of Arthrex's specialized product offerings that include suture anchors, surgical instruments, and joint replacement technologies tailored to meet the specialized healthcare requirements of veterans and military personnel. With over $550,000 in delivery orders already issued under the parent IDC, this award demonstrates Arthrex's strong competitive position and capability to efficiently deliver innovative orthopedic solutions to federal healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 4/24/25 |